Energisa S.A (ENGI3)
Sao Paulo Exchange · Brazil · prices in BRL · close of 15 Oct 2026
Key indicators
| Last close | BRL 13.50 |
|---|---|
| 52-week range | 11.26 – 15.47 |
| Return, 1 month / 3 months | +11.8% / +15.1% |
| Return, 1 year / 3 years | +18.2% / +15.6% |
| Trend | Uptrend |
| RSI (14) | 62 |
| Volatility (1 year) | 33.1% |
| Worst drawdown (1 year) | -17.7% |
| Average daily value traded | 0.06M BRL |
| Dividend yield | 2.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Energisa is a Brazilian electricity company based in Cataguases, in the state of Minas Gerais. Through its distribution subsidiaries it delivers electricity to homes, businesses, industries and rural customers across several regions of Brazil. The company also provides related services such as customer connections and energy efficiency support. Its main business is the operation of local power distribution networks, and it serves a broad base of residential and commercial users in the areas where it holds concessions.
Energisa S.A trades under the code ENGI3 on the Sao Paulo Exchange in Brazil, with its price quoted in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Energisa S.A (ENGI3) trades on the Sao Paulo Exchange in Brazil. It last closed at BRL 13.50 on 15 October 2026.
Its price-based Market X-Ray is 63 out of 100 (a fair price profile), ranking 337 of 1,454 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 18.2% and over the last three months it rose 15.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Sao Paulo Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 64 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 10.1% | ||
| From 52-week high | -10.0% | ||
| Momentum | 63 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 15.1% | ||
| 6-month return | 5.3% | ||
| 12-month return, skipping the last month | 5.7% | ||
| Stability (higher is calmer) | 71 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 33.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -17.7% | ||
| Liquidity | 54 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.06M BRL | ||
| Zero-volume days | 0.0% | ||
| Income | 52 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.9% | ||
| Years with dividends | 6 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +0.0% |
|---|---|
| 1 month | +11.8% |
| 3 months | +15.1% |
| 6 months | +5.3% |
| 1 year | +18.2% |
| 3 years | +15.6% |
| 5 years | +12.1% |
Signals
| 50-day / 200-day average | 12.28 / 12.26 |
|---|---|
| Golden / death cross (60 days) | Golden, 0 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.37 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 11 Aug 2026 | BRL 0.1000 |
| 17 Apr 2026 | BRL 0.1413 |
| 26 Nov 2025 | BRL 0.1543 |
| 12 Aug 2025 | BRL 0.2200 |
| 25 Feb 2025 | BRL 0.4180 |
| 12 Aug 2024 | BRL 0.2200 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Sao Paulo Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.